Funding name
DESARROLLO DE UNA FORMA FARMACÉUTICA ORAL A BASE DE QUITOSANO-HIERRO QUE INHIBA LA ABSORCIÓN DE ARSÉNICO EN EL TRACTO GASTROINTESTINAL
Acronym
021-2016
Funding code
021-2016
Parent funding
Expected Amount
100000
Peruvian Soles
Executed amount
100000
Peruvian Soles
Start Date
17 January 2017
End Date
17 February 2019